Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 852028, 6 pages
Review Article

When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place?

Oxford Gynaecological Cancer Centre Surgery and Diagnostics, Level 0, Churchill Hospital, Oxford OX3 7JL, UK

Received 29 April 2009; Accepted 13 September 2009

Academic Editor: Dennis S. Chi

Copyright © 2010 Igor E. Martinek and Sean Kehoe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Antonio González-Martín, Gemma Toledo, and Luis Chiva, “Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.,” Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 12, no. 6, pp. 418–30, 2010. View at Publisher · View at Google Scholar
  • Alon D. Altman, Gregg Nelson, Pamela Chu, Jill Nation, and Prafull Ghatage, “Optimal Debulking Targets in Women With Advanced Stage Ovarian Cancer: A Retrospective Study of Immediate Versus Interval Debulking Surgery,” Journal of Obstetrics and Gynaecology Canada, vol. 34, no. 6, pp. 558–566, 2012. View at Publisher · View at Google Scholar
  • Sarah Cornelis, Ben Van Calster, Frederic Amant, Karin Leunen, Ate Gerard Jan van der Zee, and Ignace Vergote, “Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC-IV Ovarian Cancer Survey Results from the Members of the European Society of Gynecological Oncology,” International Journal Of Gynecological Cancer, vol. 22, no. 3, pp. 407–416, 2012. View at Publisher · View at Google Scholar
  • Hani Gabra, and Sarah Blagden, “Epithelial Ovarian Cancer,” Dewhurst's Textbook of Obstetrics & Gynaecology, pp. 760–775, 2012. View at Publisher · View at Google Scholar
  • I Nagra, and H G Teo, “Imaging in ovarian cancer,” Imaging, vol. 22, no. 1, pp. 20100060, 2013. View at Publisher · View at Google Scholar
  • Deepa Rajan, Meeta H. Mankad, Pariseema S. Dave, Anjana S. Chauhan, Ava D. Desai, and Kalpana S. Dave, “Clinicopathological Perspectives on Endometrioid Epithelial Ovarian Carcinoma in Indian Women,” Indian Journal of Gynecologic Oncology, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Eden R. Padayachee, Fleury Augustin Nsole Biteghe, Zaria Malindi, Dirk Bauerschlag, and Stefan Barth, “Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer,” Transfusion Medicine and Hemotherapy, vol. 44, no. 5, pp. 303–310, 2017. View at Publisher · View at Google Scholar
  • Alon D. Altman, Jacob McGee, Taymaa May, Kelly Lane, Lin Lu, Wei Xu, Prafull Ghatage, and Barry Rosen, “Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study,” Gynecologic Oncology, 2017. View at Publisher · View at Google Scholar